Expired

The George M. O’Brien Kidney Resource Alliance (OKRA) is excited to announce the third offering of the OKRA Opportunity Pool Program. This program will support large pilot grants (up to a maximum of $50,000 total costs) addressing scientific and technological gaps in kidney research and promoting new collaborations.

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required). This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years. [Posted on 1/15/2023. Expires on 1/14/2026]

Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence diet, physical activity, sleep, and/or weight and thus has the potential to lower rates of chronic diseases, particularly in populations at risk for health disparities. [Posted 1/10/2025. Expires 1/12/2028]

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) The purpose of this notice of funding opportunity (NOFO) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. [Posted 11/1/2023. Expired 5/8/2025.]

Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 – Clinical Trial Not Allowed) The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research in basic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. [Posted 3/14/2024. Expired 5/24/2025]

Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to enhance the sustainability and impact of research software tools by enabling the use of best practices and design principles in software development and by leveraging continuing advances in computing. This NOFO is also expected to facilitate the creation of vibrant partnerships between developers and users of software and tools, and to promote FAIR practices for research software to maximize research value. [Posted 7/17/2024. Expired 5/24/2025.]

NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) The NIDDK Catalyst Award is designed to complement NIDDK’s traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and transformational studies in topic areas of interest to NIDDK’s Division of Diabetes, Endocrinology and Metabolic Diseases, and to NIDDK’s Division of Digestive Diseases and Nutrition. [Posted 12/18/2024. Expired 7/19/2025]

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research in basic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. [Posted 3/14/2024. Expired 05/24/2025].

Postdoctoral research position developing antimicrobial biomaterials for the urinary tract with the opportunity to apply for a TL1 training award.